If you liked this article you might like

S&P 500, Nasdaq Edge Higher as Crude Oil Rebounds From Thursday Slump
Johnson & Johnson Settles U.S. Drug Manufacturing Probe
Post Script; Takeaways and Observations: Doug Kass' Views
Johnson & Johnson Unit Sues to Block Sale of Copy of its Rheumatoid Arthritis Drug